EMAIL THIS PAGE TO A FRIEND

Cancer causes & control : CCC

Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups: a Malmö Diet and Cancer Study.


PMID 26033776

Abstract

Thyroid hormone level has been positively associated with breast cancer risk and with breast cancer cell proliferation and growth. Although breast cancer is a heterogeneous disease, this is the first study assessing pre-diagnostic levels of free triiodothyronine (fT3), free thyroxine (fT4), thyroid-stimulating hormone (TSH), and thyroid peroxidase antibodies (TPO-Ab) in relation to breast cancer subgroups and aggressiveness. The Malmö Diet and Cancer Study collected blood samples from 17,035 women between 1991 and 1996. Free T3, free T4, TSH, and TPO-Ab were analyzed in 676 incident breast cancer cases and 680 controls. Breast tumors were classified according to tumor size, axillary lymph node involvement, histological grade, histological type, hormone receptor status (ER, PgR), as well as Ki67, cyclin D1, and p27. Odds ratios of different breast cancer subgroups were calculated using a logistic regression analysis adjusted for potential confounders. High fT4 was associated with a statistically significant higher risk of overall breast cancer, small, grade I, ER-positive, PgR-positive,xa0and cyclin D1 low tumors. The associations for ER and PgR were verified in a heterogeneity analysis. Low TPO-Ab was associated with a higher risk of overall breast cancer, ductal, large, ER-positive, PgR-positive,xa0cyclin D1 low, and p27 high tumors. The heterogeneity analysis verified the association for tumor size. Free T3 was not associated with overall breast cancer risk, but in the heterogeneity analysis, high fT3 was associated with tumor size and expression of p27. There were no strong associations between TSH and overall breast cancer risk or any tumor subgroup. High pre-diagnostic fT4 levels and low pre-diagnostic TPO-Ab levels were associated with an increased risk of breast cancer. This increase was mainly limited to a higher incidence rate of less aggressive breast cancer subgroups.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

GW21985 Anti-CDKN1B antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
GW22609 Anti-CDKN1B antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1405601
Anti-CDKN1B antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2100391
Anti-CDKN1B antibody produced in rabbit, affinity isolated antibody
SAB1303143
ANTI-EREG (C-TERM) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB1408982
Anti-EREG antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB4300344
Anti-ESR1 (Ab-104) antibody produced in rabbit, affinity isolated antibody
SAB4300345
Anti-ESR1 (Ab-106) antibody produced in rabbit, affinity isolated antibody
SAB4300346
Anti-ESR1 (Ab-118) antibody produced in rabbit, affinity isolated antibody
SAB4300347
Anti-ESR1 (Ab-167) antibody produced in rabbit, affinity isolated antibody
SAB2100711
Anti-ESR1 (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2100712
Anti-ESR1 (ab2) antibody produced in rabbit, affinity isolated antibody
GW21182 Anti-ESR1 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
HPA000449
Anti-ESR1 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA000450
Anti-ESR1 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2104971
Anti-ESR1, (N-terminal) antibody produced in rabbit, affinity isolated antibody
E1396 Anti-Estrogen Receptor (154-171) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
E0521 Anti-Estrogen Receptor (18-32) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB2501316
Anti-HMGA2 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB4300681
Anti-HMGA2 antibody produced in rabbit, affinity isolated antibody
SAB2701959
Anti-HMGA2 antibody produced in rabbit
SAB1306621
ANTI-P27KIP1 (N-TERM S12) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1406263
Anti-PLG antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA021602
Anti-PLG antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2105173
Anti-PLG antibody produced in rabbit, affinity isolated antibody, lyophilized powder
A0976 Monoclonal Anti-Angiostatin antibody produced in mouse, clone 79735, purified immunoglobulin, lyophilized powder
WH0001027M1
Monoclonal Anti-CDKN1B antibody produced in mouse, clone 4B4-E6, purified immunoglobulin, buffered aqueous solution
SAB1403659
Monoclonal Anti-CDKN1B, (C-terminal) antibody produced in mouse, clone 2F4, purified immunoglobulin, buffered aqueous solution
SAB1401128
Monoclonal Anti-EREG antibody produced in mouse, clone 1E6, purified immunoglobulin, buffered aqueous solution
AMAB90867
Monoclonal Anti-ESR1 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL1196, purified immunoglobulin, buffered aqueous glycerol solution